Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
temoporfin (3 trials)
methylene blue (proveblue) (1 trial)
Bile Duct Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Ductal (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Head and Neck Neoplasms (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Trials (3 total)
Trial APIs (2 total)